Randomized Controlled Trial of Virtual Reality
Launched by GILLETTE CHILDREN'S SPECIALTY HEALTHCARE · May 8, 2018
Trial Information
Current as of June 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients receiving botulinum toxin injections at Gillette Children's Specialty Healthcare
- Exclusion Criteria:
- • Patients who are fully anesthetized during their medical procedure
- • Non-English speaking parents/patients
- • Patients with history of motion sickness
- • Patients with epilepsy
- • Patients with a ventricular shunt
- • Patients who have surgery during the study time period
About Gillette Children's Specialty Healthcare
Gillette Children's Specialty Healthcare is a leading pediatric healthcare institution dedicated to providing comprehensive, specialized care for children with complex medical conditions and disabilities. Renowned for its innovative treatment approaches and commitment to improving the quality of life for young patients, Gillette Children's combines advanced clinical research with compassionate care. The organization actively engages in clinical trials to explore new therapies and interventions, fostering advancements in pediatric healthcare and ensuring that patients have access to cutting-edge treatment options. With a focus on collaboration and excellence, Gillette Children's Specialty Healthcare is a trusted partner in the field of pediatric clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Paul, Minnesota, United States
Patients applied
Trial Officials
Chantel Burkitt, PhD
Principal Investigator
Gillette Children's Specialty Healthcare
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials